Response Biomedical Corp. Schedules Second Quarter 2013 Earnings Release and Announces Conference Call

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/07/13 -- Response Biomedical Corp. ("Response") (TSX: RBM)(OTCBB: RPBIF) will release its second quarter 2013 financial results after the markets close on August 13, 2013.

Jeffrey L. Purvin, Chief Executive Officer, will host a conference call to discuss the Q2, 2013 financial results on August 13, 2013 at 2:00 p.m. PST (5:00 p.m. EST), shortly after the initial release. Also participating in the call will be Bill Adams, Chief Financial Officer.

The conference call will be webcast live and is also available by dialing 1-877-643-7155 in North America or 1-914-495-8552 for all other locations. The conference ID number is 27515261 and participants are encouraged to initiate their calls at least 10 minutes in advance of the 2:00 p.m. PDT (5:00 p.m. EDT) start time to ensure a timely connection.

The live webcast and earnings release will be accessible from our website: . A replay of the conference call will also be available online approximately two hours after the call and for 90 days thereafter.

Response is a publicly traded company listed on the TSX under the trading symbol "RBM" and quoted on the OTC Bulletin Board under the symbol "RPBIF". For further information, please visit the Company's website at .



Contacts:
Response Biomedical Corp.
W.J. (Bill) Adams
Chief Financial Officer
604-456-6010

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 07.08.2013 - 22:38 Uhr
Sprache: Deutsch
News-ID 285771
Anzahl Zeichen: 0

contact information:
Town:

VANCOUVER, BRITISH COLUMBIA

Kategorie:

Alternative

Diese Pressemitteilung wurde bisher 244 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Response Biomedical Corp. Schedules Second Quarter 2013 Earnings Release and Announces Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von

Response Biomedical Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Response Biomedical Corp. Completes Going-Private Transaction ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/29/16 -- Response Biomedical Corp. ("Response" or the "Company") (TSX: RBM)(OTC: RPBIF) is pleased to announce that the previously announced acquisition of all the issued and ou ...

Response Biomedical Corp. Announces Third Quarter 2016 Financial Results and Upd ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/10/16 -- Response Biomedical Corp. ("Response" or "the Company") (TSX: RBM)(OTC: RPBIF) a commercial stage in-vitro medical device company with products for the laboratory and p ...

Response Biomedical Corp. Receives Court Approval of Going-Private Transaction ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/19/16 -- Response Biomedical Corp. ("Response" or the "Company") (TSX: RBM)(OTC: RPBIF) is pleased to announce that the Supreme Court of British Columbia has approved the previo ...

Alle Meldungen von Response Biomedical Corp.